¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"non Hodgkin lymphoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® non-Hodgkin lymphoma ÇÑ±Û ºñÈ£ÁöŲ ¸²ÇÁÁ¾
¼³¸í   
  ¸²ÇÁÁ¾Àº ¸²ÇÁÀý¿¡ »ý±ä ¾Ç¼º Á¾¾çÀ¸·Î ¹éÇ÷º´°ú´Â ´Ù¸£´Ù. ¹éÇ÷º´Àº °ñ¼ö¿¡¼­ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌÁö¸¸, ¸²ÇÁÁ¾Àº ¸²ÇÁÁ¶Á÷¿¡¼­ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌ´Ù. Å©°Ô ¸²ÇÁÁ¾Àº 2°¡Áö·Î ³ª´­ ¼ö Àִ µ¥, È£ÁöŲº´(Hodgkin's lymphoma)°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾(non-Hodgkin's lymphoma)À¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¶ÇÇÑ ºñÈ£ÁöŲ¸²ÇÁÁ¾Àº ¿©·¯ °¡ÁöÀÇ ¼¼Æ÷ÇüÅ¿¡ µû¶ó ³ª´©°í ÀÖ´Ù. ÀÌ º´Àº ´ÜÁö ¸²ÇÁÀý»Ó¸¸ ¾Æ´Ï¶ó Áö¶ó, °ñ¼ö, À̿ܠ´Ù¸¥ ±â°üÀ» Ä§¹üÇÔÀ¸·Î½á ¾Ç¼ºÀ̸ç, »ý¸í¿¡ Å« À§ÇùÀ» ÁØ´Ù. ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÀÏÁ¾. ÀüÀÌÀÇ ÇüŰ¡ ´Ù¾çÇÏ¿©, ÁÖÀ§ ¸²ÇÁÀýÀ» °Ç³Ê¶Ù¾î ´Ù¸¥ ¸²ÇÁÀý·Î ÀüÀÌÇϱ⵵ ÇÑ´Ù. ¶ÇÇÑ ¼¼Æ÷ÀÇ ÇüÅ¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç ´ë°³ Ä¡·á´Â ¹æ»ç¼±Ä¡·á¿Í È­Çпä¹ýÀ» º¹ÇÕÇÏ¿© »ç¿ëÇÑ´Ù.
  
  
¿µ¹® lymphoma ÇÑ±Û ¸²ÇÁÁ¾
¼³¸í   
  ¸²ÇÁÀý¿¡ »ý±ä ¾Ç¼º Á¾¾ç. ÀÌ ¾ÏÀº ¹éÇ÷º´°ú´Â ´Ù¸£´Ù. ¸²ÇÁ¼º ¹éÇ÷º´Àº °ñ¼ö¿¡¼­ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌÁö¸¸, ¸²ÇÁÁ¾Àº ¸²ÇÁÀý¿¡¼­ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌ´Ù. ¸²ÇÁÁ¾Àº Å©°Ô 2°¡Áö Áï È£ÁöŲ¸²ÇÁÁ¾(Hodgkin's lymphoma)°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾(Non-Hodgkin's lymphoma)À¸·Î ³ª´­¼ö ÀÖ´Ù. ¶ÇÇÑ ºñÈ£ÁîŲ¸²ÇÁÁ¾Àº ¿©·¯ °¡ÁöÀÇ ¼¼Æ÷ÇüÅ¿¡ µû¶ó ³ª´©°í ÀÖ´Ù. ÀÌ º´Àº ´ÜÁö ¸²ÇÁÀý»Ó¸¸ ¾Æ´Ï¶ó Áö¶ó, °ñ¼ö, À̿ܠ´Ù¸¥ ±â°üÀ» Ä§¹üÇÔÀ¸·Î½á ¾Ç¼ºÀ̸ç, »ý¸í¿¡ Å« À§ÇùÀ» ÁØ´Ù.
  
  Æ¯ÀÌÇÑ ÇüÅ·Π¹öŶ¸²ÇÁÁ¾(Burkitt's lymphoma)°¡ ÀÖ´Ù. ÀÌ º´Àº ÁַΠ¾î¸°ÀÌ¿¡°Ô ÀϾ¸ç ÁַΠÁß¾Ó ¾ÆÇÁ¸®Ä«¿¡ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ¶ÇÇÑ ÀÌ º´Àº ¹ÙÀÌ·¯½º(Ebstein Barr virus)¿¡ ÀÇÇØ¼­ ÀϾ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÁֵȠħ¹üºÎÀ§´Â ¾ó±¼ÀÇ ¾Æ·¡ÅλÀÀÌ´Ù.
  
  
¿µ¹® Hodgkin's disease ÇÑ±Û È£ÁöŲº´
¼³¸í   
  ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÇÑ ÇüÅÂÀÌ´Ù. È£ÁöŲº´Àº ¹æ»ç¼± Ä¡·á¿¡ ´ë´ÜÈ÷ ¿¹¹ÎÇØ¼­ ÃæºÐÇÑ ¾çÀÇ ¹æ»ç¼±À¸·Î ¿ÏÀüÇÑ ±ÙÄ¡Àû Ä¡·á°¡ °¡´ÉÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-Hodgkin¡¯s lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-A, non-B hepatitis
    ABÀ̿ܰ£¿°, ºñA, ºñB°£¿°
  • Hodgkin¡¯s disease
    È£ÁöŲº´
  • non compos mentis
    ½É½Å»ó½Ç»óÅÂ
  • non per os
    ±Ý½Ä
  • non-healing granuloma
    ¾Ç¼ºÀ°¾ÆÁ¾
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
  • non-lysosomal proteinase
    ºñ¿ëÇØ¼Òü´Ü¹éºÐÇØÈ¿¼Ò, ºñ¸®¼ÒÁ»´Ü¹éºÐÇØÈ¿¼Ò
  • non-neurogenic neurogenic bladder
    ºñ½Å°æ½Å°æ¼º¹æ±¤
  • non-neurogenic neuropathic bladder
    ºñ½Å°æ½Å°æº´¼º¹æ±¤
  • non-proprietary name
    ÀϹݸí
  • non-Q wave
    ºñQÆÄ
  • non-rapid eye movement
    ºñ±Þ¼Ó¾È±¸¿îµ¿
  • non-small cell carcinoma
    ºñ¼Ò¼¼Æ÷¾ÏÁ¾
  • angioimmunoblastic T-cell lymphoma
    Ç÷°ü¸é¿ª¸ð±¸T¼¼Æ÷¸²ÇÁÁ¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-atopic asthma
    ºñ¾ÆÅäÇÇõ½Ä
  • non-Q wave
    ºñÅ¥ÆÄ
  • lymphoma
    ¸²ÇÁÁ¾
  • Burkitt's lymphoma
    ¹öŶ¸²ÇÁÁ¾
  • follicular lymphoma
    ¼ÒÆ÷¸²ÇÁÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-A, non-B hepatitis
    ¿¡À̺ñÀ̿ܰ£¿°
  • atypical lymphoma
    ºñÀüÇü¸²ÇÁÁ¾
  • Burkitt lymphoma
    ¹öŶ¸²ÇÁÁ¾
  • giant follicular lymphoma
    °Å´ë¼ÒÆ÷¸²ÇÁÁ¾
  • histiocytic lymphoma
    Á¶Á÷±¸¸²ÇÁÁ¾
  • immunoblastic lymphoma
    ¸é¿ª¸ð¼¼Æ÷¸²ÇÁÁ¾
  • lymphoma
    ¸²ÇÁÁ¾
  • large cell anaplastic lymphoma
    Å«¼¼Æ÷¿ªÇü¼º¸²ÇÁÁ¾
  • lymphoblastic lymphoma
    ¸²ÇÁ¸ð±¸¸²ÇÁÁ¾
  • lymphoepithelioid lymphoma
    ¸²ÇÁ»óÇǼ¼Æ÷¸ð¾ç¸²ÇÁÁ¾
  • mantle zone cell lymphoma
    ¿ÜÅõÃþ¼¼Æ÷¸²ÇÁÁ¾
  • non-neurogenic neurogenic bladder
    ºñ½Å°æ½Å°æÅ¿¹æ±¤
  • non-neuropathic psychologic bladder
    ºñ½Å°æº´½É¸®Àû¹æ±¤
  • non-equilibratory coordination
    ºñ±ÕÇüÁ¶Á¤¿îµ¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • hepatitis,non-a, non-b
    non-A, non-B
  • NAG (non-agglutinable) vibrio
    ºñÀÀÁý¼º ºñºê¸®¿À
  • NPN= non protein nitrogen
    ºñ´Ü¹éÁú¼Ò.
  • NSAID =non steroidal antiinflammatory
    ºñ½ºÅ׷ε强 Ç׿°Áõ¾à¹°, ~¼Ò¿°Á¦
  • NSAID= non steroidal antiinflammatory
    ºñ½ºÅ׷ε强 Ç׿°Áõ¾à¹°.
  • granuloma, non-healing
    ¾à¼ºÀ°¾ÆÁ¾
  • reaction of non-identity
    ºÒÀÏÄ¡¹ÝÀÀ
  • B cell lymphoma
    B¼¼Æ÷¸²ÇÁÁ¾
  • Burkitts lymphoma
    ¹öŰƮ¸²ÇÁÁ¾
  • Burkitts lymphoma
    ¹öŰƮ¸²ÇÁÁ¾.
  • Burkitts lymphoma
    ¹öŶƮ ¸²ÇÁÁ¾
  • Ki-1 lymphoma
    Ki-1 ¸²ÇÁÁ¾
  • T cell lymphoma
    T¼¼Æ÷¸²ÇÁÁ¾
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾.
  • non hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾(¡­ðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-A, non-B, non-C hepatitis
    ºñA ºñB ºñC °£¿°
  • non-Hodgkins lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-hodgkins lymphoma
    ¸û¸ù¸û¸²ÇÁÁ¾(¡­ðþ)
  • hepatitis,non-a, non-b
    non-A, non-B
  • non-A, non-B, hepatitis=NANBH
    ºñAºñB °£¿°
  • adult t-cell leukemia/lymphoma
    ¼º¼÷ T-¼¼Æ÷ ¹éÇ÷º´/¸²ÇÁÁ¾(à÷âÙ¡­á¬øà ÛÜúìÜ»/¡­ðþ)
  • angiotropic (intravascular) large cell lymphoma
    Ç÷°ü¿µ¾ç¼º(Ç÷°ü³»)´ë¼¼Æ÷¸²ÇÁÁ¾
  • atypical lymphoma
    ÀÌÇü<ºñÁ¤Çü>¸²ÇÁÁ¾(?Ì¡).
  • burkitts lymphoma
    ¹öŰƮ¸²ÇÁÁ¾(¡­ðþ)
  • burkitts lymphoma,epstein-barr virus
    ¿¦½ºÅ¸ÀÎ-¹Ù ¹ÙÀÌ·¯½º
  • cutaneous B cell lymphoma
    ÇǺΠB¼¼Æ÷¸²ÇÁÁ¾
  • cutaneous T cell lymphoma
    ÇǺΠT ¼¼Æ÷¸²ÇÁÁ¾.
  • cutaneous T cell lymphoma
    ÇǺΠT ¼¼Æ÷¸²ÇÁÁ¾
  • cutaneous t cell lymphoma
    ÇǺΠT ¼¼Æ÷¸²ÇÁÁ¾(ù«Ý±¡­ðþ)
  • giant follicular lymphoma
    °Å´ë¿©Æ÷¼º ¸²ÇÁÁ¾.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Non-keratinized epithelium
    (ºñ°¢Áú»óÇÇ)
    [¿¾ ¿ë¾î] ºñ°¢È­»óÇÇ
  • Non-villous placenta
    ¹«À¶¸ðŹÝ
    [¿¾ ¿ë¾î] ¹«À¶¸ð¼ºÅ¹Ý
  • Non-disjunction
    ºñºÐ¸®
    [¿¾ ¿ë¾î] ºñºÐ¸®
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-biting midge
    ±òµû±¸
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-Mendelian inheritance
    ºñ(Þª)¸àµ¨ À¯Àü(ë¶îî)
  • non-Newtonian fluid
    ºñ(Þª)´º¿ìÅÏ À¯Ã¼(×µô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • Hodgkin's disease
    È£ÁîŲº´
  • Burkitt's lymphoma
    ¹öŰƮ¸²ÇÁÁ¾
  • centroblastic lymphoma
    Áß½É¸ð¼¼Æ÷¸²ÇÁÁ¾
  • centrocytic lymphoma
    Á߽ɼ¼Æ÷¸²ÇÁÁ¾
  • diffuse large cell lymphoma
    ¹Ì¸¸¼º Å«¼¼Æ÷ÀÓÆÄÁ¾
  • lymphoma
    ¸²ÇÁÁ¾
  • non-communicating
    ºñ±³Å뼺
  • non-enhanced image
    ºñÁ¶¿µÁõ°­¿µ»ó
  • non-focused transducer
    ºñÃÊÁ¡ÇüŽÃËÀÚ
  • non-invasive
    ºñ°üÇ÷ÀûÀÎ, ºñħ½ÀÀû, ºñħ½À¼º, ºñħÀ±¼º
  • non-ionic contrast medium
    ºñÀ̿¼º Á¶¿µÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NHL nodular histiocytic lymphoma; non-Hodgkin lymphoma
NHL Non-Hodgkin's Lymphoma
HL hairline; hairy leukoplakia; half life; hearing level; hearing loss; heparin lock; histiocytic lymph...
NHML non-Hodgkin malignant lymphoma
T-NHL T-cell-derived non-Hodgkin leukemia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
B-NHL B cell non Hodgkin's lymphoma
B-NHL B non Hodgkin's lymphoma
NHL Non Hodgkin Lymphoma
LGNHL Low-grade non-Hodgkin's lymphoma
NHML Non Hodgkin Malignant Lymphoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ ¸²ÇÁÁ¾
  • Hodgkin's disease
    È£ÁîŲ º´, È£ÁöŲ º´, Hodgkin º´
    µ¿ÀǾî=malignant lym
  • angiotropic intravascular large cell lymphoma
    Ç÷°ü ¿µ¾ç¼º Ç÷°ü³» ´ë¼¼Æ÷ ¸²ÇÁÁ¾
  • atypical lymphoma
    ÀÌÇü ¸²ÇÁÁ¾, ºñÁ¤Çü ¸²ÇÁÁ¾
  • B cell lymphoma
    B ¼¼Æ÷ ¸²ÇÁÁ¾
    ¾Ç¼º ¸²ÇÁÁ¾ Áß¿¡¼­ ¥ì¼â, DR Ç׿ø, Leu-10ÀÇ B ¸²ÇÁ±¸ Ç¥½ÃÀÚ°¡ Áõ¸íµÈ ¸²ÇÁÁ¾ÀÌ´Ù. Áõ¸íµÈ Ç¥½ÃÀÚ´Â °³°³ÀÇ Áõ·Ê¿¡ µû¶ó ´Ù¸£°í ¥ì+, DR+ Leu-10+ÀÇ ÀüÇüÀûÀÎ ¿¹·ÎºÎÅÍ DR ³»Áö Leu-10¸¸ÀÌ ¾ç¼ºÀÎ Áõ·Ê¿¡ À̸£±â±îÁö ±× º¯È­´Â ´Ù¾çÇÏ´Ù. ÇüÅÂÀûÀÎ ºÐ·ù¿¡ ÀÇÇÑ °áÀý¼º ¸²ÇÁÁ¾, ¸²ÇÁÇüÁú ¼¼Æ÷¼º ¸²ÇÁÁ¾, ¹èÁ᫐ ¼¼Æ÷¿¡¼­ À¯·¡ÇÏ´Â ¸²ÇÁÁ¾, Burkitt ¸²ÇÁÁ¾ µîÀÌ B¼¼Æ÷ ¸²ÇÁÁ¾¿¡ ¼ÓÇÑ´Ù.
  • Burkitt's lymphoma
    ¹öŰƮ¸²ÇÁÁ¾, ¹öŶ ¸²ÇÁÁ¾, Burkitt ÀÓÆÄÁ¾
    1. ¾Ç°ñÀ» ÀÏÂ÷ÀûÀ¸·Î ħ¹üÇÏ´Â µ¶Æ¯ÇÑ Á¾¾ç. 2. ÅÎÀÇ ºü¸¥ ¼ºÀåÀ» º¸ÀÌ´Â Á¾¾ç, °ñ ÆÄ±«¿Í Ä¡¾ÆÀÇ µ¿¿ä°¡ ³ªÅ¸³­´Ù.
  • Burkitts lymphoma
    ¹öŰƮ ¸²ÇÁÁ¾
  • cutaneous B cell lymphoma
    ÇǺΠB ¼¼Æ÷ ¸²ÇÁÁ¾
  • lymphoma
    ÀÓÆÄÁ¾, ¸²ÇÁÁ¾
    Hodgkin º´À» Æ÷ÇÔÇÏ¿© ¸²ÇÁ¾ç Á¶Á÷ÀÇ Á¾¾ç¼º º´º¯À» ÃÑĪÇÏ´Â ÀÏ¹Ý ¿ë¾î. ¾ç¼º ¸²ÇÁÁ¾Àº µå¹°¸ç, lym
  • mantle zone lymphoma
    ¿ÜÅõ Ãþ ¸²ÇÁÁ¾
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾
  • nonHodgkin's lymphoma
    ºñÈ£ÁöŲ ¸²ÇÁÁ¾
  • T-cell leukemia-lymphoma virus
    T Çü ¼¼Æ÷ ¹éÇ÷º´-ÀÓÆÄÁ¾ ¹ÙÀÌ·¯½º
  • bleaching-non-vital
    ½ÇȰ Ä¡¼ö Ç¥¹é
  • cell cycle-non specific
    ¼¼Æ÷ Áֱ⠺ñƯÀ̼º Á¦Á¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
cancer, lymphoma, non-hodgkin's A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy.
(12 Dec 1998)
non-Hodgkin's lymphoma <oncology, tumour> A group of lymphomas which differ in important ways from Hodgkin's disease and are classified according to the microscopic appearance of the cancer cells. The disease is classified as either low grade (slowly growing), intermediate grade or high grade (rapidly growing) and may be treated in a variety of ways depending on the exact diagnosis. Previously called lymphosarcoma.
(30 Sep 1997)
lymphoma, non-hodgkin Any of a group of malignant tumours of lymphoid tissue that differ from hodgkin disease, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumours is the absence of giant reed-sternberg cells, a characteristic of hodgkin's disease.
(12 Dec 1998)
non-A, non-B, non-C hepatitis Hepatitis caused by viral organisms other than hepatitis viruses A, B or C.
(05 Mar 2000)
cancer, lymphoma, hodgkin's A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia.
(12 Dec 1998)
Hodgkin's lymphoma <haematology, oncology> A human malgnant disorder of lymph tissue (lymphoma) that appears to originate in a particular lymph node and later spreads to the spleen, liver and bone marrow. It occurs mostly in individuals between the ages of 15 and 35. It is characterised by progressive, painless enlargement of the lymph nodes, spleen and general lymph tissue.
Giant cells, the Reed Sternberg cells, with mirror image nuclei are diagnostic. Immunological depletion, caused perhaps by the excessive growth of neoplastic histiocytes, occurs.
Four types of the disease are recognised depending on the relative predominance of various neoplastic derivatives of the lymphoid series. Pyrexia is often a feature of the disease.
Death often results from generalised immunological inability to respond to infections. If detected early, it has a high remission rate.
Staging: Ann Arbor classification; each stage is further classified as:, A no symptoms, B fever, sweats, weight loss.
Stage I - involvement of a single lymph-node region or extralymphatic site.
Stage II - two or more sites of involvement on the same side of the diaphragm.
Stage III - disease involvement on both sides of the diaphragm.
Stage IV - disseminated disease of extralymphatic organs, with or without lymph-node involvement.
Indicence: approximately 1,500 new cases per year in the UK.
(30 Mar 2000)
hepatitis non-A, non-B <virology> A virus somewhat similar in size to Hepatitis A but has no antigenic cross reaction with either A or B. Many of the cases are in fact hepatitis C and this was the old term for hepatitis C.
(20 Sep 2002)
non-A, non-B hepatitis Hepatitis caused by two or more infectious agents not detectable by methods that reveal the presence of hepatitis viruses A and B; one cause, now called type C hepatitis has been identified; may follow blood transfusion and is often seen in chronic renal dialysis patients.
Synonym: NANB hepatitis.
(05 Mar 2000)
non-A, non-B hepatitis virus Term used to group any of a number of viruses, other than A or B, which cause hepatitis in humans.
(05 Mar 2000)
cancer, hodgkin's disease A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia.
(12 Dec 1998)
Goldman-Hodgkin-Katz equation An equation derived to predict membrane potentials in terms of the membrane's permeability to ions and their concentrations on either side.
Synonym: constant field equation, Goldman-Hodgkin-Katz equation, GHK equation.
(05 Mar 2000)
Hodgkin, Alan <person> British physiologist and Nobel laureate, *1914.
See: Goldman-Hodgkin-Katz equation.
(05 Mar 2000)
Hodgkin-Key murmur <cardiology, clinical sign> A musical diastolic murmur associated with retroversion of an aortic cusp; often very loud.
(05 Mar 2000)
Hodgkin's disease <haematology, oncology> A human malgnant disorder of lymph tissue (lymphoma) that appears to originate in a particular lymph node and later spreads to the spleen, liver and bone marrow. It occurs mostly in individuals between the ages of 15 and 35. It is characterised by progressive, painless enlargement of the lymph nodes, spleen and general lymph tissue.
Giant cells, the Reed Sternberg cells, with mirror image nuclei are diagnostic. Immunological depletion, caused perhaps by the excessive growth of neoplastic histiocytes, occurs.
Four types of the disease are recognised depending on the relative predominance of various neoplastic derivatives of the lymphoid series. Pyrexia is often a feature of the disease.
Death often results from generalised immunological inability to respond to infections. If detected early, it has a high remission rate.
Staging: Ann Arbor classification; each stage is further classified as:, A no symptoms, B fever, sweats, weight loss.
Stage I - involvement of a single lymph-node region or extralymphatic site.
Stage II - two or more sites of involvement on the same side of the diaphragm.
Stage III - disease involvement on both sides of the diaphragm.
Stage IV - disseminated disease of extralymphatic organs, with or without lymph-node involvement.
Indicence: approximately 1,500 new cases per year in the UK.
(30 Mar 2000)
Hodgkin, Thomas <person> British physician, 1798-1866.
See: Hodgkin's disease, Hodgkin-Key murmur, non-Hodgkin's lymphoma.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hodgkin's disease
    È£ÁöŲ º´(¾Ç¼º À°¾ÆÁ¾Áß)
  • non sequitur
    ±×¸©µÈ °á·Ð
  • non-essential
    ºñº»ÁúÀûÀÎ
  • non-homogeneous
    ÀÌÁúÀÇ
  • dies non
    (L)(¹ý)ÈÞÁ¤ÀÏ;À¯¾÷ÀÏ
  • non Euclidean
    ºñ À¯Å¬¸®µåÀÇ
  • non assumpsit
    (¹ý)Àμö¼Ò¼Û(assumpsit)¿¡¼­ÇǰíÀÇ °è¾à ºÎÀÎÀÇ ´äº¯
  • non compos(mentis)
    ¿ÇÀº Á¤½ÅÀÌ ¾Æ´Ñ;Á¤½ÅÀÌ»óÀÇ(insane)
  • non est
    Á¸ÀçÇÏÁö ¾Ê´Â;ºÎÀçÀÇ
  • non est inventus
    º»ÀμÒÀç ºÒ¸í
  • non liquet
    ÀçÆÇ ¿¬±âÀÇ ¹è½ÉÆò°á
  • non obs(t).
    non obstante
  • non obstante
    ..¿¡µµ ºÒ±¸Çϰí
  • non placet
    (±³È¸,´ëÇÐÀÇ Áýȸ¿¡¼­)ÀÌÀÇ;¹Ý´ëÅõÇ¥
  • non plus ultra
    NE PLUS ULTRA
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á